$SNOA
Sonoma Pharmaceuticals, Inc.

2024 Q1 Form 10-Q Financial Statement

#000168316824000781 Filed on February 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $3.439M $3.138M
YoY Change 14.1% 6.59%
Cost Of Revenue $2.348M $1.678M
YoY Change 9.82% -20.59%
Gross Profit $1.091M $1.460M
YoY Change 24.54% 75.69%
Gross Profit Margin 31.72% 46.53%
Selling, General & Admin $2.091M $1.703M
YoY Change 15.52% -36.1%
% of Gross Profit 191.66% 116.64%
Research & Development $409.0K $601.0K
YoY Change 103.48%
% of Gross Profit 37.49% 41.16%
Depreciation & Amortization $41.00K $45.00K
YoY Change 20.59% 40.63%
% of Gross Profit 3.76% 3.08%
Operating Expenses $2.500M $2.304M
YoY Change 24.32% -13.55%
Operating Profit -$1.409M -$844.0K
YoY Change 24.14% -53.98%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $50.00K -$79.00K
YoY Change -116.45% 8.22%
Pretax Income -$1.359M -$923.0K
YoY Change -5.56% -51.55%
Income Tax -$292.0K -$57.00K
% Of Pretax Income
Net Earnings -$1.067M -$866.0K
YoY Change -18.43% -55.34%
Net Earnings / Revenue -31.03% -27.6%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.07 -$0.08
COMMON SHARES
Basic Shares Outstanding 15.61M shares 13.68M shares
Diluted Shares Outstanding 10.91M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.128M $2.406M
YoY Change -18.12% -8.66%
Cash & Equivalents $3.128M $2.406M
Short-Term Investments
Other Short-Term Assets $3.803M $4.265M
YoY Change -16.38% 23.55%
Inventory $2.719M $2.955M
Prepaid Expenses
Receivables $2.898M $2.876M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.55M $12.50M
YoY Change -9.06% 11.31%
LONG-TERM ASSETS
Property, Plant & Equipment $365.0K $397.0K
YoY Change -25.2% 26.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $66.00K $78.00K
YoY Change -9.59% -74.68%
Total Long-Term Assets $2.192M $2.116M
YoY Change -9.91% -21.51%
TOTAL ASSETS
Total Short-Term Assets $12.55M $12.50M
Total Long-Term Assets $2.192M $2.116M
Total Assets $14.74M $14.62M
YoY Change -9.19% 4.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $607.0K $864.0K
YoY Change -27.82% -33.64%
Accrued Expenses $2.311M $2.028M
YoY Change 1.14% -18.13%
Deferred Revenue
YoY Change
Short-Term Debt $323.0K $44.00K
YoY Change -25.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.719M $3.074M
YoY Change 0.05% -21.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $4.884M $4.852M
YoY Change 7.65% 9.77%
Total Long-Term Liabilities $4.884M $4.852M
YoY Change 7.65% 32246.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.719M $3.074M
Total Long-Term Liabilities $4.884M $4.852M
Total Liabilities $8.603M $7.926M
YoY Change 4.23% -5.29%
SHAREHOLDERS EQUITY
Retained Earnings -$194.3M -$193.3M
YoY Change 2.55% 2.7%
Common Stock $203.2M $202.8M
YoY Change 1.14% 2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.137M $6.692M
YoY Change
Total Liabilities & Shareholders Equity $14.74M $14.62M
YoY Change -9.19% 4.95%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.067M -$866.0K
YoY Change -18.43% -55.34%
Depreciation, Depletion And Amortization $41.00K $45.00K
YoY Change 20.59% 40.63%
Cash From Operating Activities $152.0K -$1.100M
YoY Change -106.23% 216.09%
INVESTING ACTIVITIES
Capital Expenditures -$3.000K $0.00
YoY Change -101.58% -100.0%
Acquisitions
YoY Change
Other Investing Activities $15.00K $0.00
YoY Change -86.11% -100.0%
Cash From Investing Activities $18.00K $0.00
YoY Change -121.95% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 622.0K 1.314M
YoY Change -81.55% -513.21%
NET CHANGE
Cash From Operating Activities 152.0K -1.100M
Cash From Investing Activities 18.00K 0.000
Cash From Financing Activities 622.0K 1.314M
Net Change In Cash 792.0K 214.0K
YoY Change -6.71% -133.86%
FREE CASH FLOW
Cash From Operating Activities $152.0K -$1.100M
Capital Expenditures -$3.000K $0.00
Free Cash Flow $155.0K -$1.100M
YoY Change -105.89% 190.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 SNOA Adjustment To Correct Par Value
AdjustmentToCorrectParValue
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001367083
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33216
dei Entity Registrant Name
EntityRegistrantName
SONOMA PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0423298
dei Entity Address Address Line1
EntityAddressAddressLine1
5445 Conestoga Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
Boulder
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80301
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
759-9305
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
SNOA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15607433 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2406000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3820000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2876000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2572000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2955000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2858000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4009000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4308000 usd
CY2023Q4 SNOA Deferred Consideration Net Current
DeferredConsiderationNetCurrent
256000 usd
CY2023Q1 SNOA Deferred Consideration Net Current
DeferredConsiderationNetCurrent
240000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
12502000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
13798000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
488000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
418000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
922000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
949000 usd
CY2023Q4 SNOA Deferred Consideration Net Noncurrent
DeferredConsiderationNetNoncurrent
378000 usd
CY2023Q1 SNOA Deferred Consideration Net Noncurrent
DeferredConsiderationNetNoncurrent
505000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73000 usd
CY2023Q4 us-gaap Assets
Assets
14618000 usd
CY2023Q1 us-gaap Assets
Assets
16231000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
864000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
841000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1847000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2029000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
75000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
100000 usd
CY2023Q4 SNOA Contract With Customer Liability Current Invekra
ContractWithCustomerLiabilityCurrentInvekra
63000 usd
CY2023Q1 SNOA Contract With Customer Liability Current Invekra
ContractWithCustomerLiabilityCurrentInvekra
60000 usd
CY2023Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
44000 usd
CY2023Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
431000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
256000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3074000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3717000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
101000 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
140000 usd
CY2023Q4 SNOA Withholding Tax Payable
WithholdingTaxPayable
4591000 usd
CY2023Q1 SNOA Withholding Tax Payable
WithholdingTaxPayable
4235000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
160000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7926000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
8254000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13684333 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13684333 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4933550 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4933550 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202795000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
200904000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193282000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189514000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2823000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3418000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6692000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7977000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14618000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16231000 usd
CY2023Q4 us-gaap Revenues
Revenues
3138000 usd
CY2022Q4 us-gaap Revenues
Revenues
2944000 usd
us-gaap Revenues
Revenues
9296000 usd
us-gaap Revenues
Revenues
10258000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1678000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2113000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5642000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6645000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
1460000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
831000 usd
us-gaap Gross Profit
GrossProfit
3654000 usd
us-gaap Gross Profit
GrossProfit
3613000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
601000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1462000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1703000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2665000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5484000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7030000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
2304000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
2665000 usd
us-gaap Operating Expenses
OperatingExpenses
6946000 usd
us-gaap Operating Expenses
OperatingExpenses
7036000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-844000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1834000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3292000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3423000 usd
CY2023Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-79000 usd
CY2022Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-71000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-380000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-322000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-923000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1905000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3672000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3745000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-57000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
96000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-866000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3843000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10909000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10909000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3107000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3107000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7011000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7011000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3104000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3104000 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-866000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3843000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
297000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
235000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
595000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
136000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-569000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1704000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3173000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3707000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3843000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
447000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
569000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
92000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-244000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
221000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-129000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
93000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
162000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-546000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-572000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-99000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-94000 usd
SNOA Increase Decrease In Deferred Consideration Net Of Discount
IncreaseDecreaseInDeferredConsiderationNetOfDiscount
161000 usd
SNOA Increase Decrease In Deferred Consideration Net Of Discount
IncreaseDecreaseInDeferredConsiderationNetOfDiscount
129000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-12000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-353000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-226000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
346000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
33000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1204000 usd
SNOA Increase Decrease In Withholding Tax Payable
IncreaseDecreaseInWithholdingTaxPayable
356000 usd
SNOA Increase Decrease In Withholding Tax Payable
IncreaseDecreaseInWithholdingTaxPayable
259000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-99000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-94000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2550000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3711000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
-0 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
97000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-176000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1446000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
SNOA Payments Of Atm Agreement Costs
PaymentsOfAtmAgreementCosts
5000 usd
SNOA Payments Of Atm Agreement Costs
PaymentsOfAtmAgreementCosts
89000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
120000 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
387000 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
674000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1054000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-883000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1414000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4762000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3820000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7396000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2406000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2634000 usd
us-gaap Interest Paid Net
InterestPaidNet
15000 usd
us-gaap Interest Paid Net
InterestPaidNet
12000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7977000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-5000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
177000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
511000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1418000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7242000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
130000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-213000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1484000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5675000 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1446000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
140000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
297000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-866000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6692000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
8697000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
214000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-65000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-887000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7959000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
108000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
5000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-34000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1017000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7021000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
233000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
9000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3104000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
235000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1939000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5559000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-866000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3843000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193282000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189514000 usd
CY2023Q4 SNOA Working Capital
WorkingCapital
9428000 usd
CY2023Q1 SNOA Working Capital
WorkingCapital
10081000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2406000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3820000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2550000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3711000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_ziZJxTYRNYm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zr7AewO31CFi">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates and assumptions include reserves and write-downs related to receivables and inventories, the valuation allowance relating to the Company’s deferred tax assets, valuation of equity and the estimated amortization periods of upfront product licensing fees received from customers. Periodically, the Company evaluates and adjusts estimates accordingly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-866000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3843000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10909000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10909000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3107000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3107000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7011000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7011000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3104000 shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1011000 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
730000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1011000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
730000 shares
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 SNOA Allowance For Sales Discounts Rebates Distributor Fees And Returns
AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns
29000 usd
CY2023Q1 SNOA Allowance For Sales Discounts Rebates Distributor Fees And Returns
AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns
16000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
292000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
236000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9296000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1507000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1764000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1448000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1094000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2955000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2858000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
418000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
256000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
160000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
328000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
99000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P21M15D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
38000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
134000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
175000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
34000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
381000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
40000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
341000 usd
us-gaap Officers Compensation
OfficersCompensation
586000 usd
CY2023Q4 SNOA Potential Severance Payments
PotentialSeverancePayments
1300000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
140000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
242000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
447000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
569000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0249 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0643 pure
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3138000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2944000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9296000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10258000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3138000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2944000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10258000 usd

Files In Submission

Name View Source Status
0001683168-24-000781-index-headers.html Edgar Link pending
0001683168-24-000781-index.html Edgar Link pending
0001683168-24-000781.txt Edgar Link pending
0001683168-24-000781-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snoa-20231231.xsd Edgar Link pending
snoa-20231231_cal.xml Edgar Link unprocessable
sonoma_ex1041.htm Edgar Link pending
sonoma_ex1042.htm Edgar Link pending
sonoma_ex3101.htm Edgar Link pending
sonoma_ex3102.htm Edgar Link pending
sonoma_ex3201.htm Edgar Link pending
sonoma_i10q-123123.htm Edgar Link pending
snoa-20231231_lab.xml Edgar Link unprocessable
snoa-20231231_pre.xml Edgar Link unprocessable
sonoma_i10q-123123_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
snoa-20231231_def.xml Edgar Link unprocessable